First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors

Publication Date

2024

Content Type

Article

PubMed ID:

38551394

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS